NCT02534610View on ClinicalTrials.gov

Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Postoperative Pain
Interventions
DRUG

Etoricoxib

120 mg etoricoxib PO administered 1 h preoperative for group A; group B received 120 mg etoricoxib PO at the end of the surgery.

DRUG

Placebo

Group A received 1 sham pill PO at the end of the surgery; group B received 1 sham pill PO 1 h preoperative and group C received sham pill PO 1 h preoperative and 1 sham pill PO at the end of the surgery.

Trial Locations (1)

021382

Foisor Orthopedics Clinical Hospital, Bucharest

All Listed Sponsors
lead

Foisor Orthopedics Clinical Hospital

OTHER

NCT02534610 - Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter